Sr. Clinical Research Associate/Clinical Trial Manager (Fully Remote)

BridgeBio Inc.; United States; A distancia; USD 110.000 - 170.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Unlimited PTO

Employer-paid health coverage

401(k) match

Employee stock purchase plan

Remote-friendly with SF visits

Descripción de la vacante

BridgeBio Inc. is seeking a capable clinical operations professional to support clinical studies from planning through close-out. You will ensure compliance with Good Clinical Practice and standard operating procedures while coordinating across teams and vendors.

This role emphasizes reliability, attention to regulatory detail, and cross-functional collaboration. The position offers a remote-first work model with periodic visits to the San Francisco area, aligning with a fast-paced,

Responsabilidades

• Collaborate with Clinical Operations to support clinical studies from planning through close-out, ensuring compliance with GCP and SOPs.

Descripción del empleo

• BridgeBio is a biopharmaceutical company discovering and delivering transformative medicines for patients with genetic diseases and cancers.
• Founded in 2015, the company has built a portfolio of 20+ drug development programs across multiple therapeutic areas.

Role Responsibilities:

• Collaborate with Clinical Operations to support clinical studies from planning through close-out, ensuring compliance with GCP and SOPs.
• Lead site initiation, performance monitoring, risk mitigation, and vendor management for assigned regions.
• Contribute to study documents, regulatory submissions, and maintain an inspection-ready Trial Master File.

Benefits and Culture:

• Enjoy unlimited PTO, 100% employer-paid medical, dental, and vision coverage, and generous parental leave.
• Access financial rewards including market-leading compensation, 401(k) match, and employee stock purchase program.
• Work in a remote environment with quarterly visits to the San Francisco office, supporting a collaborative, quality-focused culture.

BridgeBio

BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines for patients with genetic diseases and cancers with clear genetic drivers. Founded in 2015, the company has built a portfolio of 20+ drug development programs spanning preclinical to late-stage development across multiple therapeutic areas.